Funding

All authors participated in an SARS-CoV-2 expert panel convened between February and June 2022, for which they received an honorarium sponsored by Roche Diagnostics. Medical writing support and open access publication fees were provided by Roche Diagnostics International Ltd, Rotkreuz, Switzerland.